We first confirm CHMP4C offers lung cancer cells radioresistance, which will provide a potential radio-therapeutic strategy for non-small cell lung cancer by disrupting CHMP4C expression. The gene discussed is CHMP4C; the disease is non-small cell lung carcinoma.